A high throughput and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MS/MS

Talanta

Volumn 72, Issue 1, 2007, Pages 80-88

  Jain, Deepak S ^a,b   Subbaiah, Gunta ^b   Sanyal, Mallika ^c   Shrivastav, Pranav ^a  

^a GUJARAT UNIVERSITY   (India)

^b Torrent Pharmaceuticals Ltd   (India)

^c ST XAVIER S COLLEGE   (India)

Author keywords

Human plasma; LC MS MS; Pseudo selective reaction monitoring (SRM); Solid phase extraction; Valproic acid

Indexed keywords

DRUG PRODUCTS; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN);

HUMAN PLASMA; HYDROPHILIC LIPOPHILIC BALANCE (HLB); SELECTIVE REACTION MONITORING (SRM); SOLID PHASE EXTRACTION; VALPROIC ACID;

ORGANIC ACIDS;

EID: 33947320467     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2006.09.033     Document Type: Article

References (21)

1. Willmore L.J. Psychopharmacology 37 (2003) 43
2. Lin M.-C., Kou H.-S., Chen C.-C., Wu S.-M., and Wu H.-L. J. Chromatogr. B 810 (2004) 169
3. Lucarelli C., Villa P., Lombardi E., Prandini P., and Brega A. Chromatographia 33 (1992) 37
4. Wolf J.H., Veenma-Van der Duin L., and Korf J. J. Chromatogr. 487 (1989) 496
5. Van der Horst F.A.L., Eikelboom G.G., and Holthuis J.J.M. J. Chromatogr. 456 (1988) 191
6. Nakamura M., Kondo K., Nishioka R., and Kawai S. J. Chromatogr. 310 (1984) 450
7. Amini H., Javan M., and Ahmadiani A. J. Chromatogr. B 830 (2006) 368
8. Pucci V., Mandrioli R., and Raggi M.A. Electrophoresis 24 (2003) 2076
9. Lian J.J., Tianalin W., and Sam F.Y.L. Electrophoresis 20 (1999) 1856
10. Nakajima M., Yamato S., Shimada K., Sato S., Kitagaba S., Honda A., Miyamoto J., Shoda J., Ohya M., and Miyazaki H. Ther. Drug Monit. 22 (2000) 716
11. Gaetani E., Laureri C.F., and Vitto M. J. Pharm. Biomed. Anal. 10 (1992) 193
12. Speed D.J., Dickson S.J., Cairns E.R., and Kim N.D. J. Anal. Toxicol. 24 (2000) 685
13. Susanto F., and Reinauer H. Chromatographia 41 (1995) 407
14. Darius J. J. Chromatogr. B. 682 (1996) 67
15. Fisher E., Wittfoht W., and Nau H. Biomed. Chromatogr. 6 (1992) 24
16. Yu D., Gordon J.D., Zheng J., Panesar S.K., Riggs K.W., Rurak D.W., and Abbott F.S. J. Chromatogr. B 666 (1995) 269
17. Deng C., Li N., Ji J., Yang B., Duan G., and Zhang X. Rapid Commun. Mass Spectrom. 20 (2006) 1281
18. Ramakrishna N.V., Vishwottam K.N., Manoj S., Koteshwara M., Santosh M., Chidambara J., and Kumar B.R. Rapid Commun. Mass Spectrom. 19 (2005) 1970
19. Bowden C.L., Janicak P.G., Orsulak P., Swann A.C., Davis J.M., Calabrese J.R., Goodnick P., Small J., Rush A.J., Kaimmel S.E., Risch S.C., and Morris D.D. Am. J. Psychiatry 153 (1996) 765
20. Pucci V., Monteagudo E., and Bonelli F. Rapid Commun. Mass Spectrom. 19 (2005) 3713
21. FDA Guidance for Industry: Bioavailability Studies for Orally Administered Drug- Products-General Considerations, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), 2000.